Interferon beta-1a biosimilar (Dong-A ST)
干扰素β-1a生物类似药 (Dong-A ST)
Report date: 2022/01/14 13:23:58
Base Information
Drug NameInterferon beta-1a biosimilar (Dong-A ST)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesDong-A Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC Code
Related LinksN/A